| scholarly article | Q13442814 |
| P2093 | author name string | C B Thompson | |
| C S Duckett | |||
| J L Van Dongen | |||
| M C Gilfillan | |||
| R W Gedrich | |||
| P2860 | cites work | A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40 | Q24306620 |
| Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 | ||
| FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis | Q24307362 | ||
| RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death | Q24307376 | ||
| Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma | Q24315735 | ||
| Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 | ||
| CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF | Q24316162 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation | Q24318742 | ||
| Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease | Q24324634 | ||
| The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit | Q27860669 | ||
| The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
| Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay | Q28251086 | ||
| The CD40 antigen and its ligand | Q28286277 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| CD30-mediated signaling promotes the development of human T helper type 2-like T cells | Q36672795 | ||
| The two different receptors for tumor necrosis factor mediate distinct cellular responses | Q37609601 | ||
| Cytokines and STATs: how can signals achieve specificity? | Q40451329 | ||
| Contenders in FasL/TNF death signaling | Q40530231 | ||
| CD30, Th2 cytokines and HIV infection: a complex and fascinating link | Q40611296 | ||
| Cross-linking of CD30 induces HIV expression in chronically infected T cells | Q41342620 | ||
| Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis | Q41343773 | ||
| Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. | Q41727367 | ||
| CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection | Q41779853 | ||
| Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death | Q46725238 | ||
| Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells | Q59090441 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12852-8 | |
| P577 | publication date | 1996-05-31 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins | |
| P478 | volume | 271 |
| Q41094987 | 12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562. |
| Q24533857 | 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB |
| Q24291050 | A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains |
| Q102054075 | A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma |
| Q42165830 | A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. |
| Q39392332 | AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells |
| Q28263653 | Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation |
| Q40813696 | Activation of c-Jun N-terminal kinase in the absence of NFkappaB function prior to induction of NK cell death triggered by a combination of anti-class I and anti-CD16 antibodies |
| Q48528844 | Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. |
| Q33699315 | Antigen presenting cells integrate opposing signals from CD4+ and CD8+ regulatory T lymphocytes to arbitrate the outcomes of immune responses |
| Q35925874 | Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily |
| Q36718807 | BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients |
| Q24647213 | CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand |
| Q40177590 | CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells |
| Q35996947 | CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2 |
| Q33747241 | CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation. |
| Q24605401 | CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival |
| Q42631651 | Characterization and expression analysis of TNFR-associated factor 1 (TRAF1) in grass carp Ctenopharyngodon idella |
| Q39879963 | Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. |
| Q40733134 | Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells |
| Q42441496 | Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation |
| Q36004058 | Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 |
| Q41682745 | Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. |
| Q34428468 | Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling |
| Q28255713 | Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor |
| Q29618716 | Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice |
| Q34095134 | Expression and function of TRAF-3 splice-variant isoforms in human lymphoma cell lines |
| Q35788035 | Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms |
| Q38331230 | Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells |
| Q33713375 | Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling |
| Q28207526 | Hodgkin's lymphoma and CD30 signal transduction |
| Q28245341 | Identification and characterization of an IkappaB kinase |
| Q73980580 | Identification and characterization of two CD40-inducible enhancers in the mouse TRAF1 gene locus |
| Q28280342 | Identification and functional characterization of DR6, a novel death domain-containing TNF receptor |
| Q36566021 | Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. |
| Q33786551 | Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression |
| Q40736248 | Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells |
| Q36959865 | Lymphoma microenvironment: culprit or innocent? |
| Q24564927 | Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB |
| Q42807549 | Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis |
| Q57203665 | NF-κB as an emerging target in atopy |
| Q33919859 | Neurotrophin receptor structure and interactions |
| Q74746971 | Neurotrophin receptors: mediators of life and death |
| Q28208696 | Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family |
| Q34996759 | Reactive oxygen intermediates in TNF signaling |
| Q28137640 | Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase |
| Q42775424 | Regulation of CD30 antigen expression and its potential significance for human disease |
| Q78631997 | Regulation of lymphocyte clustering by CD30-mediated ICAM-1 up-regulation |
| Q24679579 | Retracted: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation |
| Q39550436 | Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP. |
| Q31927630 | Structure of the Hodgkin's lymphoma-associated human CD30 gene and the influence of a microsatellite region on its expression in CD30(+) cell lines. |
| Q40027786 | Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines |
| Q35183220 | Systemic and primary cutaneous anaplastic large cell lymphomas |
| Q30578474 | TNF receptor associated factors in cytokine signaling. |
| Q37266849 | TNF superfamily: costimulation and clinical applications |
| Q28142929 | TRAF-3 interacts with p62 nucleoporin, a component of the nuclear pore central plug that binds classical NLS-containing import complexes |
| Q33876001 | TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation |
| Q24313308 | TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation |
| Q28138885 | TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis |
| Q73925277 | TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival |
| Q35125212 | TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation |
| Q57492396 | TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation |
| Q22253885 | TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation |
| Q52522634 | Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. |
| Q40850973 | The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. |
| Q35997566 | The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation |
| Q28589608 | The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2 |
| Q95789811 | The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity |
| Q35850668 | The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation |
| Q22254032 | The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation |
| Q35145613 | The signaling adaptors and pathways activated by TNF superfamily |
| Q27619945 | The structural basis for the recognition of diverse receptor sequences by TRAF2 |
| Q40905330 | The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation |
| Q35192167 | Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry |
| Q41343487 | Trans-signaling by cytokine and growth factor receptors |
| Q40375572 | Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma |
| Q24642851 | Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 |
| Q41056335 | Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-kappaB activation |
| Q28301504 | Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation |
| Q36400170 | Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. |
| Q28199382 | Tumor necrosis factor receptor-associated factors (TRAFs) |
| Q24676338 | Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40 |
| Q24304221 | VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activation |
Search more.